Medications

Gilead wins India patent for blockbuster Hepatitis drug

India has granted a patent to US pharmaceutical giant Gilead for a blockbuster Hepatitis C drug, in a U-turn activists said could potentially stop affordable copies reaching millions of people in other countries.

Addiction

Coffee drinking improves hepatitis C treatment response

Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association ...

Diseases, Conditions, Syndromes

Why severe fatty liver leads to liver damage

In hepatic steatosis, hepatocytes "die," resulting in liver damage. Severe steatosis increases hepatocellular deaths, thus aggravating liver damage. The mechanism is unclear. Using mice, we show that mild steatosis causes ...

Medical research

How liver kills 'killer cells'

Our livers can fight back against the immune system -- reducing organ rejection but also making us more susceptible to liver disease.

page 5 from 35